Digital Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Revenue Model (Subscription and Value-Based), Application, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) – Market Fore

Digital Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Revenue Model (Subscription and Value-Based), Application, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) – Market Forecast, 2024–2032

The digital therapeutics market size is expected to reach USD 70.63 billion by 2032, according to a new study by Polaris Market Research. The report “Digital Therapeutics Market Size, Share, Trends, Industry Analysis Report: By Revenue Model (Subscription and Value-Based), Application, End Users, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) – Market Forecast, 2024–2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The digital therapeutics market growth is driven by increasing internet access globally in developed as well as developing countries. For instance, according to statistics of Our World in Data, in 2000, 7% of the Asian population had access to the internet, while just 3% of the African region was online. By 2016, the population share with internet access increased significantly, with 91% of the population in South Korea and Japan having internet access and 97% of the population in Denmark and Norway online. After six years, in 2022, major regions of Africa witnessed 81% of the population share gain internet access.

Government initiatives and incentives in order to digitalize the whole ecosystem are anticipated to boost the digital therapeutics market during the forecast years. Increased government funding in the healthcare sector and the introduction of schemes for the digitalization of the healthcare sector are expected to fuel the digital therapeutics market during the study time. For instance, in August 2023, the government of India introduced the Digital Health Incentive Scheme (DHIS) under the Ayushman Bharat Digital Mission (ABDM) to encourage the adoption of digital health, laboratories, and health tech companies. In the digital health incentive scheme, new health tech startups will be offered incentives up to 4 crore INR.

Employers and patients are the major consumers of digital therapeutic services. Major companies have started adding therapies as services in their employee packages, providing lifestyle management, depression, and hypertension-related services. Patients with chronic diseases, such as diabetes and cardiovascular diseases, can use the services for day-to-day consultation.

Digital Therapeutics Market Report Highlights

• By revenue model analysis, the subscription segment is anticipated to experience substantial growth in the global market. This growth is attributed to major advantages that are associated with the subscription-based revenue model.
• By end users analysis, the employers segment is anticipated to dominate the market from 2024 to 2032 due to major companies globally having started including digital therapeutics packages in their services.
• In 2023, North America dominated the digital therapeutics market due to the large share of the population having internet access and increasing digitalization.
• The digital therapeutics market in India is projected for substantial growth due to the regulatory support and initiatives for the digitalization of the healthcare sector.

The key market players are Proteus Digital Health, Inc.; Fitbit, Inc.; Pear Therapeutics, Inc.; Kaia Health; Happify, Inc.; Medtronic Plc.; Omada Health, Inc.; Livongo Health, Inc.; Voluntis Inc.; Resmed, Inc.; Welldoc, Inc.; 2Morrow Inc.; Canary Health; and Mindable Health GmbH.

Polaris Market Research has segmented the digital therapeutics market report based on revenue model, application, end users, and region:

By Revenue Model Outlook (Revenue - USD billion, 2019–2032)

Subscription

Value-based

One Time Purchase

By Application Outlook (Revenue – USD billion, 2019–2032)

Diabetes

Obesity

CVD

CNS Disease

Respiratory Diseases

Smoking Cessation

Lifestyle Management

Preventive Applications

Others

By End Users Outlook (Revenue – USD billion, 2019–2032)

Patients

Providers

Payers

Employers

Others

By Regional Outlook (Revenue – USD billion, 2019–2032)

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Australia
• Rest of Asia Pacific

Latin America

• Argentina
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa
• Rest of the Middle East & Africa